10/1/24 17:54 | 9/27/24 | WVE | Wave Life Sciences Ltd. | X0 | Health | Drug | Pharmaceutical Preparations | Gsk Plc | X0 | T | | P | 22,335 | 8.00 | 0 | 2,792 | 20 | 16,776 | I | | | | | | | | | | | | | | |
1/30/24 16:39 | 12/7/23 | WVE | Wave Life Sciences Ltd. | X0 | Health | Drug | Pharmaceutical Preparations | Gsk Plc | X0 | T | | P | 16,500 | 5.00 | 0 | 3,300 | 31 | 13,984 | I | | | | | | | | | | | | | | |
7/6/21 16:38 | 7/2/21 | CVRX | Cvrx, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.d | 4,950 | 18.00 | 0 | 275 | 38 | 1,008 | I | | | | | | | | | | | | | | |
2/19/21 16:50 | 2/17/21 | DBTX | Decibel Therapeutics, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | D | | P.d | 2,700 | 18.00 | 0 | 150 | 15 | 1,184 | I | | | | | | | | | | | | | | |
7/30/20 20:56 | 7/24/20 | GNCA | Genocea Biosciences, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.d | 2,836 | 2.25 | 0 | 1,261 | 37 | 4,626 | I | | | | | | | | | | | | | | |
7/22/20 16:18 | 7/21/20 | PAND | Pandion Therapeutics, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | DT | | P.d | 6,500 | 18.00 | 0 | 361 | 19 | 2,248 | I | | | | | | | | | | | | | | |
7/16/20 20:13 | 7/14/20 | NKTX | Nkarta, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | DT | | P.d | 15,000 | 18.00 | 0 | 833 | 36 | 3,151 | I | | | | | | | | | | | | | | |
5/26/20 16:17 | 5/21/20 | TPTX | Turning Point Therapeutics, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | D | | P | 5,000 | 60.00 | 0 | 83 | 4 | 2,254 | I | | | | | | | | | | | | | | |
10/22/19 17:36 | 10/18/19 | PRNB | Principia Biopharma Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | H | Former 1 | P | 10,000 | 28.00 | 0 | 357 | 14 | 2,983 | I | | | | | | | | | | | | | | |
9/12/19 16:18 | 9/10/19 | TPTX | Turning Point Therapeutics, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | D | | P | 8,000 | 45.00 | 0 | 178 | 9 | 2,170 | I | | | | | | | | | | | | | | |
7/2/19 16:13 | 7/1/19 | MORF | Morphic Holding, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | D | | P.d | 5,000 | 15.00 | 0 | 333 | 14 | 2,634 | I | | | | | | | | | | | | | | |
6/26/19 10:46 | 6/24/19 | GNCA | Genocea Biosciences, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 6,500 | 3.50 | 0 | 1,857 | 123 | 3,366 | I | | | | | | | | | | | | | | |
5/30/19 17:47 | 5/28/19 | BCYC | Bicycle Therapeutics Plc | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | DT | | P.d | 5,400 | 14.00 | 0 | 386 | 25 | 1,915 | I | | | | | | | | | | | | | | |
4/24/19 19:28 | 4/22/19 | TPTX | Turning Point Therapeutics, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | DT | | P.d | 5,850 | 18.00 | 0 | 325 | 19 | 1,993 | I | | | | | | | | | | | | | | |
9/20/18 17:18 | 9/18/18 | PRNB | Principia Biopharma Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.d | 4,590 | 17.00 | 0 | 270 | 11 | 2,626 | I | | | | | | | | | | | | | | |
8/1/18 18:32 | 7/30/18 | LQDA | Liquidia Technologies Inc | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | H | Former 1 | P.d | 1,637 | 11.00 | 0 | 149 | 31 | 624 | I | | | | | | | | | | | | | | |
7/17/18 17:01 | 7/17/18 | SPRO | Spero Therapeutics, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 1,000 | 12.50 | 0 | 80 | 4 | 1,934 | I | | | | | | | | | | | | | | |
7/3/18 17:59 | 7/2/18 | TBIO | Translate Bio, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.d | 3,500 | 13.00 | 0 | 269 | 8 | 3,698 | I | | | | | | | | | | | | | | |
11/7/17 19:42 | 11/6/17 | SPRO | Spero Therapeutics, Inc. | X0 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.d | 6,000 | 14.00 | 0 | 429 | 30 | 1,854 | I | | | | | | | | | | | | | | |
10/26/16 17:49 | 10/24/16 | CRSP | Crispr Therapeutics AG | X0 | Health | BioPrd | Biological Products, (No Diag | Glaxosmithkline Plc | X0 | T | | P.d | 931 | 14.00 | 7 | 67 | 2 | 3,221 | I | | | | | | | | 3 | 7 | 22 | 31 | 26 | 15 | |
3/15/16 16:31 | 3/14/16 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 2,147,484 | 23,028,000 | 3 | 1,301 | 16 | 9,645 | I | | -9 | 27 | 5 | 10 | 23 | 0 | 1 | 5 | 8 | 29 | 31 | 80 | 75 |
10/7/15 16:31 | 10/7/15 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 2,147,484 | 607,544 | 3 | 45 | 1 | 8,344 | I | | -46 | -30 | 5 | 3 | -6 | 0 | 12 | 3 | 5 | 36 | 25 | 67 | 199 |
8/7/15 16:18 | 8/7/15 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.e | 3,486 | 14.18 | 8 | 246 | 1 | 32,005 | I | -51 | -31 | 16 | -8 | -26 | -13 | -11 | -5 | 3 | -3 | 12 | -35 | | |
5/13/15 12:36 | 5/11/15 | HTGM | Htg Molecular Diagnostics, Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Glaxosmithkline Plc | | T | | P.d | 5,111 | 14.00 | 4 | 365 | 53 | 1,049 | I | | | | | | | | 1 | 1 | 1 | 9 | -48 | -58 | -83 |
5/11/15 15:40 | 5/11/15 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | | T | | P.e | 1,369 | 16.00 | 12 | 86 | 0 | 31,759 | I | -34 | -23 | 13 | 28 | -3 | -4 | -6 | -4 | 1 | 2 | 12 | -9 | -41 | |
3/2/15 15:45 | 3/2/15 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.e | 1,674 | 18.06 | 16 | 93 | 0 | 31,674 | I | 13 | -41 | -20 | 18 | 55 | 43 | 17 | 6 | 6 | 9 | -7 | -5 | -21 | |
11/4/14 13:50 | 11/4/14 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | | T | | P.e | 12,787 | 15.36 | 20 | 832 | 3 | 31,581 | I | -14 | -47 | -29 | -29 | -12 | -5 | -11 | -2 | -1 | -13 | -11 | -20 | 4 | -37 |
8/11/14 16:55 | 8/11/14 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.e | 3,912 | 22.66 | 25 | 173 | 1 | 30,749 | I | 4 | -24 | -23 | 5 | -25 | -19 | 3 | 3 | 1 | 3 | -7 | -33 | -38 | -29 |
5/13/14 16:43 | 5/9/14 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.e | 8,545 | 26.89 | 33 | 318 | 1 | 30,576 | I | 23 | -24 | -21 | -29 | -14 | -3 | 0 | -2 | 7 | 2 | 21 | 2 | -34 | -24 |
4/2/14 12:42 | 4/1/14 | AGTC | Applied Genetic Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Glaxosmithkline Plc | X0 | T | | P.d | 1,245 | 12.00 | 7 | 104 | 6 | 1,990 | I | | | | | | | | 6 | 5 | -5 | -19 | 44 | 19 | 33 |
2/20/14 18:56 | 2/19/14 | CNCE | Concert Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | H | Former 1 | P.d | 490 | 14.00 | 18 | 35 | 1 | 2,678 | I | | | | | | | | -1 | 5 | 6 | 2 | -46 | -32 | 7 |
2/13/14 16:41 | 2/11/14 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.e | 12,851 | 37.55 | 33 | 342 | 1 | 30,258 | I | 121 | 78 | 4 | 9 | 8 | 0 | 7 | 5 | 3 | 4 | -12 | -25 | -27 | -54 |
2/12/14 17:56 | 2/10/14 | GNCA | Genocea Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Glaxosmithkline Plc | X0 | H | Former 1 | P.d | 1,725 | 12.00 | 5 | 144 | 9 | 1,672 | I | | | | | | | | 4 | -2 | 3 | 59 | 60 | 10 | -24 |
11/22/13 11:59 | 11/20/13 | FOLD | Amicus Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 3,000 | 2.00 | 1 | 1,500 | 15 | 11,316 | I | -25 | -57 | -39 | -21 | -8 | -2 | 1 | 0 | -2 | 18 | 1 | 23 | 7 | 237 |
10/29/13 17:37 | 10/29/13 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.e | 4,914 | 37.66 | 33 | 130 | 0 | 29,916 | I | 73 | 50 | 12 | 3 | -8 | 2 | 7 | 4 | -3 | -2 | -1 | -1 | -28 | -45 |
8/1/13 09:23 | 7/30/13 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.e | 111,851 | 36.50 | 33 | 3,064 | 11 | 29,786 | I | 74 | 29 | 74 | 15 | 9 | -10 | 0 | 5 | 0 | -4 | -6 | -3 | -2 | -30 |
4/30/13 14:38 | 4/30/13 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.e | 6,699 | 34.61 | 33 | 194 | 1 | 26,721 | I | 26 | 61 | 43 | 64 | 47 | 54 | 6 | 13 | -3 | -5 | 2 | 5 | 13 | -22 |
2/20/13 15:04 | 2/15/13 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.e | 2,567 | 22.03 | 27 | 117 | 0 | 26,528 | I | -8 | 23 | -17 | 10 | 2 | 1 | 0 | 0 | -1 | -8 | 6 | 66 | 61 | 81 |
11/5/12 13:38 | 11/2/12 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P.e | 6,266 | 22.35 | 9 | 280 | 1 | 26,411 | I | 1 | -1 | 0 | -25 | -19 | -18 | -12 | -15 | 4 | 2 | 3 | 8 | 53 | 75 |
8/7/12 12:54 | 8/3/12 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 8,924 | 28.21 | 30 | 316 | 1 | 26,131 | I | 57 | 40 | 47 | 30 | 33 | -12 | -10 | -2 | 1 | -3 | -10 | -19 | -17 | 37 |
8/3/12 16:26 | 8/1/12 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Glaxosmithkline Plc | X0 | DT | | P.m | 973,744 | 14.25 | 0 | 68,333 | 41 | 233,717 | I | | | | | | | | | | | | | | |
8/1/12 17:28 | 7/30/12 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Glaxosmithkline Plc | X0 | DT | | P.m | 95,802 | 14.25 | 0 | 6,723 | 4 | 165,384 | I | | | | | | | | | | | | | | |
7/17/12 17:17 | 7/17/12 | FOLD | Amicus Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 18,582 | 6.30 | 2 | 2,950 | 43 | 9,816 | I | 172 | -18 | 23 | 30 | 40 | 14 | 0 | 2 | 8 | -12 | -13 | 7 | -34 | -61 |
5/16/12 09:29 | 5/16/12 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 212,887 | 21.29 | 11 | 10,000 | 63 | 25,814 | I | 51 | -15 | -5 | 19 | -8 | 0 | 8 | -1 | -1 | -1 | -14 | 22 | -7 | 83 |
2/14/12 12:57 | 2/14/12 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 1,603 | 18.12 | 11 | 88 | 1 | 15,814 | I | 87 | -27 | -2 | -17 | -18 | 1 | 1 | 1 | 0 | 1 | 1 | 21 | 44 | 22 |
11/3/11 14:25 | 11/1/11 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 1,298 | 22.23 | 8 | 58 | 0 | 15,726 | I | 54 | 6 | -14 | 15 | 8 | 2 | -6 | -5 | 6 | 2 | 9 | -14 | -7 | 1 |
8/3/11 13:43 | 8/2/11 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 2,020 | 19.71 | 9 | 102 | 1 | 15,668 | I | 26 | 21 | -14 | -24 | -16 | -25 | -25 | -16 | 5 | 4 | 2 | 20 | 0 | 49 |
5/4/11 12:26 | 5/3/11 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 6,689 | 25.60 | 11 | 261 | 4 | 6,164 | I | 69 | 49 | 19 | 14 | 7 | -4 | -11 | -14 | 2 | 8 | -4 | -24 | -9 | -12 |
2/22/11 12:07 | 2/18/11 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 3,609 | 23.70 | 14 | 152 | 3 | 5,902 | I | 51 | 121 | 61 | 1 | -8 | 7 | -7 | -7 | -5 | 1 | 2 | 13 | -22 | -19 |
11/30/10 12:13 | 11/29/10 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 129,375 | 22.50 | 10 | 5,750 | New | 5,750 | I | 285 | 92 | 91 | 103 | 12 | 22 | 16 | 16 | -1 | 4 | 2 | -10 | 4 | -17 |
11/24/10 12:21 | 11/24/10 | ANAC | Anacor Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | | P | 5,000 | 5.00 | 0 | 1,000 | 56 | 2,771 | I | | | | | | | | | | | | | | |
7/14/05 21:50 | 7/12/05 | CRXA | Corixa Corp | DE | Health | BioPrd | Biological Products, (No Diag | Glaxosmithkline Plc | X0 | T | | P | 265,989 | 4.62 | 0 | 57,565 | | 0 | D | | | | | | | | | | | | | | |